期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Dermic-derived fibroblasts for the study of amyotrophic lateral sclerosis 被引量:2
1
作者 Javier Riancho Sara Arozamena Adolfo Lopez de Munain 《Neural Regeneration Research》 SCIE CAS CSCD 2020年第11期2043-2044,共2页
Among neurodegenerative diseases,amyotrophic lateral sclerosis(ALS)is the most frequent one involving motor neurons(MNs).ALS incidence varies throughout the world ranging from 0.7 to 4 cases per 100,000 habitants and ... Among neurodegenerative diseases,amyotrophic lateral sclerosis(ALS)is the most frequent one involving motor neurons(MNs).ALS incidence varies throughout the world ranging from 0.7 to 4 cases per 100,000 habitants and year(Riancho et al.,2016).This disease,which currently lacks an effective therapy,is characterized by a variable combination of upper and lower MN degeneration,leading to progressive muscle wasting which usually results in a terminal respiratory failure within 3 years after symptom onset(Zufiria et al.,2016).A small proportion of ALS cases show familial aggregation.These are related to mutations in specific causative genes(Cr9ORF72,TARDBP,FUS,SOD1 and others)which directly determine disease onset in carriers.By contrast,more than 90 percent of cases are considered to be sporadic,in which generally unknown environmental and internal factors interact with genetic predisposing factors finally leading to disease(Riancho et al.,2018).From a histopathological point of view,ALS is characterized by MN damage and loss.MNs from ALS sporadic and most of familial patients exhibit prominent transactive response DNA-binding protein 43(TDP-43)cytoplasmic aggregates which are considered as the“pathological hallmark”of the disease,excepting those related to SOD1 and FUS mutations(Zufiria et al.,2016).TDP-43 is a DNA/RNA binding protein encoded by the TARDBP gene that controls the expression of many different genes. 展开更多
关键词 al. amyotrophic DEGENERATION
下载PDF
胆固醇降得越低越好吗?
2
作者 Uffe Ravnskov Paul J Rosch +3 位作者 Morley C Sutter Mark C Houston 杨靓(译) 刘靖(校) 《英国医学杂志中文版》 2006年第5期303-305,共3页
美国关于 LDL-C 水平的建议使得多数西方国家的成年人处于他汀的治疗范围内他汀的剂量有可能超过现在使用剂量8倍以上阿托伐他汀剂量增加8倍并未降低死亡率临床试验中的副作用未被充分报告任何非致死性事件的下降都可以被更多。
关键词 国家胆固醇教育计划 低密度脂蛋白胆固醇 高危人群 强化治疗 心血管疾病 西方国家 他汀 副作用
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部